Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The need to strengthen laboratory leadership, systems, and networks to enhance outbreak detection and resilience in Africa: proceedings of a regional workshop.

BMC proceedings·2026
Same author

Clonal expansion of global pneumococcal sequence cluster 3 within serotype 8 after 13-valent pneumococcal conjugate vaccine introduction, South Africa.

Microbial genomics·2026
Same author

Public Health Response to Toxigenic Respiratory Diphtheria Outbreaks at Correctional Facility, South Africa, 2023-2025.

Emerging infectious diseases·2026
Same author

Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications.

EClinicalMedicine·2026
Same author

Identification and genomic characterization of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa.

Virus evolution·2026
Same author

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence.

The Lancet. Microbe·2026

Video Experimental Relacionado

Updated: Jun 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Evolución neumocócica rápida en respuesta a las intervenciones clínicas.

Nicholas J Croucher1, Simon R Harris, Christophe Fraser

  • 1The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Science (New York, N.Y.)
|January 29, 2011
PubMed
Resumen
Este resumen es generado por máquina.

La plasticidad genómica en Streptococcus pneumoniae permite una rápida adaptación. Este patógeno bacteriano sufre recombinación frecuente, lo que permite una rápida evolución de la resistencia y la evasión inmune, lo que afecta a las intervenciones de salud pública.

Más Videos Relacionados

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Videos de Experimentos Relacionados

Last Updated: Jun 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Área de la Ciencia:

  • Microbiología Microbiología.
  • La genómica es la genómica.
  • Epidemiología La epidemiología.

Sus antecedentes:

  • Los patógenos bacterianos naturalmente transformables como Streptococcus pneumoniae presentan desafíos en los estudios epidemiológicos debido a las altas tasas de recombinación.
  • Distinguir las mutaciones verdaderas de la transferencia horizontal de genes es crucial para comprender la evolución bacteriana.

Objetivo del estudio:

  • Investigar la plasticidad genómica y la dinámica evolutiva del linaje PMEN1 multirresistente de Streptococcus pneumoniae.
  • Para diferenciar las sustituciones de bases de los eventos de recombinación en una gran colección de aislamientos.

Principales métodos:

  • Secuenciación del genoma completo de 240 aislamientos de Streptococcus pneumoniae del linaje PMEN1.
  • Análisis de datos de secuencias para identificar y cuantificar eventos de recombinación y sustituciones de bases.
  • El seguimiento de los cambios genéticos asociados con la resistencia a los antimicrobianos y el cambio de cápsulas.

Principales resultados:

  • Se detectaron más de 700 eventos de recombinación dentro de los aislados secuenciados.
  • Los genes que codifican los antígenos principales se vieron afectados con frecuencia por la recombinación, incluidos 10 eventos de conmutación de cápsulas.
  • Se han observado múltiples evoluciones independientes de la resistencia a las fluoroquinolonas, rifampicina y macrólidos.
  • Un evento de conmutación de cápsulas correlacionado con la aparición del serotipo 19A de escape de la vacuna en los Estados Unidos después de la introducción de la vacuna.

Conclusiones:

  • La plasticidad genómica en Streptococcus pneumoniae facilita la rápida adaptación a las presiones selectivas, incluidas las intervenciones clínicas.
  • Las bacterias recombinógenas pueden desarrollar resistencias y estrategias de evasión inmunológica en escalas de tiempo cortas.
  • Comprender estas dinámicas evolutivas es fundamental para desarrollar estrategias efectivas de control contra los patógenos bacterianos.